Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01070342 · ClinicalTrials.gov registry record
Ambulatory Blood Pressure Monitoring in Children
A clinical trial of Blood Pressure, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 170
- Enrollment target
- 2
- Study locations
NCT01070342: Completed study of Blood Pressure, sponsored by University Hospitals Cleveland Medical Center.
NCT01070342 is a study of Blood Pressure that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 170 participants, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01070342, a study of Blood Pressure, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
- 2
- Study locations
Study Summary
Ambulatory Blood Pressure Monitoring (ABPM) potentially offers a superior way to screen children for entry into antihypertensive trials, assuring that only those with true hypertension are enrolled.10 In addition, ABPM offers a better method to measure response to drug therapy.11-16 The ABPM device most commonly used in children (Spacelabs 90217 - Issaquah, Washington) has not been independently validated for use in this population. In 1993, the British Hypertension Society (BHS) published a protocol for validating ABPM devices, including guidance for validation studies in children.17 More recently, the Working Group on Blood Pressure Monitoring of the European Society of Hypertension published revisions to these guidelines, but did not include children in this update.18 Unfortunately, the original BHS protocol suggests using a smaller group of children than the protocol outlines for adults. Since BP in children is more variable than in adults, this guidance is unlikely to be adequate for children. Hence, a large, stringent validation study needs to be conducted in a cohort of children using the methods similar to those used to validate the device in adults. Performance of the proposed validation study is needed to allow for the incorporation of ABPM into clinical trial designs of anti-hypertensives in children which will ultimately allow for more accurate identification of the hypertensive population and determination of response to therapy along with allowing for assessment of the chronobiologic profile of drug response over the dosing interval.9
Conditions Studied
Interventions
- DEVICE Spacelabs 90217
Study Locations (2)
Arkansas
- Arkansas Children's Hospital Research Institute - Little Rock
Kentucky
- University of Louisville Research Foundation, Inc. - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-02 |
What the finished NCT01070342 record still lists
NCT01070342 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (40% lower).
The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Spacelabs 90217 is the first listed.
NCT01070342 reports a single indexed study location in Arkansas, Kentucky.
Frequently Asked Questions
What is clinical trial NCT01070342 about?
NCT01070342 is a clinical study titled "Ambulatory Blood Pressure Monitoring in Children". Ambulatory Blood Pressure Monitoring (ABPM) potentially offers a superior way to screen children for entry into antihypertensive trials, assuring that only those with true hypertension are enrolled.10 In addition, ABPM offers a better method to measure response to drug therapy.11-16 The ABPM device ...
What is the current status of trial NCT01070342?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2010-02. Estimated completion is 2011-02.
What conditions does trial NCT01070342 study?
This clinical trial studies the following conditions: Blood Pressure.
What interventions are being tested in trial NCT01070342?
The interventions under investigation include: Spacelabs 90217 (DEVICE).
Who is sponsoring clinical trial NCT01070342?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01070342 being conducted?
This trial has 2 study locations across Arkansas, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01070342's enrollment target sits among peer trials
170 22nd of 101 higher than 79 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements
RECRUITING
-
The GUARDIAN Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia